Vigilant Biosciences

ORISDX

This company develops non-invasive salivary diagnostic tests for early oral cancer detection, serving dentists, oncologists and primary care providers.

Cellectgen

This company develops point-of-care saliva testing tools and mobile applications to help dentists identify risks of gum disease and dental implant failure.

Bristle Health

This company provides oral microbiome saliva tests and probiotics for consumers and dental practitioners to monitor and improve oral health.

Naveris

This molecular diagnostics company develops and commercialises liquid biopsy tests for the early detection and clinical management of viral-associated cancers for healthcare providers.

Cleveland Diagnostics

This company develops blood-based protein biomarker tests for early cancer detection to help clinicians and laboratories identify high-risk patients and reduce unnecessary biopsies.

Glycanostics

This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.

AnchorDx

This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.

Predicta Biosciences

This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.